Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature

Descripción del Articulo

Introduction: Impulse control disorders have been reported in patients with Parkinson’s disease (PD), and in users of dopamine agonists. We report three cases of patients with parkinsonian symptoms and hypersexuality, an impulse control disorder associated with pramipexole use. Case reports: Case 1:...

Descripción completa

Detalles Bibliográficos
Autores: Custodio, Nilton, Montesinos, Rosa, Lira, David, Torres, Hernando
Formato: artículo
Fecha de Publicación:2010
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/72
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72
Nivel de acceso:acceso abierto
Materia:Agonistas dopaminérgicos
enfermedad de Parkinson
trastorno de control de impulsos
conducta sexual.
Dopamine agonists
Parkinson disease
impulse control disorders
sexual behavior.
id REVUNMSM_cc70d18bd3fd7894c48ba2f3bad024e2
oai_identifier_str oai:ojs.csi.unmsm:article/72
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
dc.title.none.fl_str_mv Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
Hipersexualidad asociada a pramipexol, en el tratamiento de síntomas parkinsonianos: revisión de la literatura, a propósito de 3 casos
title Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
spellingShingle Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
Custodio, Nilton
Agonistas dopaminérgicos
enfermedad de Parkinson
trastorno de control de impulsos
conducta sexual.
Dopamine agonists
Parkinson disease
impulse control disorders
sexual behavior.
title_short Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
title_full Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
title_fullStr Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
title_full_unstemmed Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
title_sort Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
dc.creator.none.fl_str_mv Custodio, Nilton
Montesinos, Rosa
Lira, David
Torres, Hernando
author Custodio, Nilton
author_facet Custodio, Nilton
Montesinos, Rosa
Lira, David
Torres, Hernando
author_role author
author2 Montesinos, Rosa
Lira, David
Torres, Hernando
author2_role author
author
author
dc.subject.none.fl_str_mv Agonistas dopaminérgicos
enfermedad de Parkinson
trastorno de control de impulsos
conducta sexual.
Dopamine agonists
Parkinson disease
impulse control disorders
sexual behavior.
topic Agonistas dopaminérgicos
enfermedad de Parkinson
trastorno de control de impulsos
conducta sexual.
Dopamine agonists
Parkinson disease
impulse control disorders
sexual behavior.
description Introduction: Impulse control disorders have been reported in patients with Parkinson’s disease (PD), and in users of dopamine agonists. We report three cases of patients with parkinsonian symptoms and hypersexuality, an impulse control disorder associated with pramipexole use. Case reports: Case 1: A 62-year-old man with PD treated with levodopa/carbidopa. He needed to start pramipexole and twelve months later he presented hypersexuality that improved with escitalopram. Case 2: A 66-year-old man with PD treated with levodopa/carbidopa, entacapone and clonazepam. He needed to start pramipexole; sixteen months later he presented hypersexuality that disappeared with escitalopram. Case 3: A 45-year-old man with Parkinsonism secondary to acute disseminated encephalomyelitis treated with risperidone, amitriptyline and clonazepam. He needed to start pramipexole; two months later, he presented hypersexuality and received escitalopram; hypersexuality disappeared only when decreasing pramipexole dose; then he started levodopa/carbidopa and hypersexuality reappeared that decreased again when reducing levodopa/carbidopa dose. Conclusions: Pramipexole may be associated with hypersexuality, but it is necessary to be careful with characteristics either related to disease or to individual factors. Hypersexuality may improve with escitalopram and its associated symptoms should be treated.
publishDate 2010
dc.date.none.fl_str_mv 2010-03-15
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72
10.15381/anales.v71i1.72
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72
identifier_str_mv 10.15381/anales.v71i1.72
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72/67
dc.rights.none.fl_str_mv Derechos de autor 2010 Nilton Custodio, Rosa Montesinos, David Lira, Hernando Torres
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2010 Nilton Custodio, Rosa Montesinos, David Lira, Hernando Torres
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 71 No. 1 (2010); 51-3
Anales de la Facultad de Medicina; Vol. 71 Núm. 1 (2010); 51-3
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238239508889600
spelling Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literatureHipersexualidad asociada a pramipexol, en el tratamiento de síntomas parkinsonianos: revisión de la literatura, a propósito de 3 casosCustodio, NiltonMontesinos, RosaLira, DavidTorres, HernandoAgonistas dopaminérgicosenfermedad de Parkinsontrastorno de control de impulsosconducta sexual.Dopamine agonistsParkinson diseaseimpulse control disorderssexual behavior.Introduction: Impulse control disorders have been reported in patients with Parkinson’s disease (PD), and in users of dopamine agonists. We report three cases of patients with parkinsonian symptoms and hypersexuality, an impulse control disorder associated with pramipexole use. Case reports: Case 1: A 62-year-old man with PD treated with levodopa/carbidopa. He needed to start pramipexole and twelve months later he presented hypersexuality that improved with escitalopram. Case 2: A 66-year-old man with PD treated with levodopa/carbidopa, entacapone and clonazepam. He needed to start pramipexole; sixteen months later he presented hypersexuality that disappeared with escitalopram. Case 3: A 45-year-old man with Parkinsonism secondary to acute disseminated encephalomyelitis treated with risperidone, amitriptyline and clonazepam. He needed to start pramipexole; two months later, he presented hypersexuality and received escitalopram; hypersexuality disappeared only when decreasing pramipexole dose; then he started levodopa/carbidopa and hypersexuality reappeared that decreased again when reducing levodopa/carbidopa dose. Conclusions: Pramipexole may be associated with hypersexuality, but it is necessary to be careful with characteristics either related to disease or to individual factors. Hypersexuality may improve with escitalopram and its associated symptoms should be treated.Introducción: Los desórdenes del control de los impulsos han sido reportados en pacientes con enfermedad de Parkinson (EP), así como en usuarios de agonistas dopaminérgicos. Comunicamos tres casos de pacientes con síntomas parkinsonianos e hipersexualidad, un desorden del control de los impulsos, asociado al uso de pramipexol. Casos clínicos: Caso 1: Varón de 62 años de edad con EP en tratamiento con levodopa/carbidopa, que requirió inicio de pramipexol; a los doce meses presentó hipersexualidad que remitió parcialmente con escitalopram. Caso 2: Varón de 66 años de edad con EP en tratamiento con levodopa/carbidopa, entacapona y clonazepam; requirió inicio de pramipexol y a los dieciséis meses presentó hipersexualidad, que remitió totalmente con escitalopram. Caso 3: Varón de 45 años de edad con parkinsonismo secundario a encefalitis esclerosante aguda en tratamiento con risperidona, amitriptilina y clonazepam; requirió inicio de pramipexol; a los dos meses presentó hipersexualidad, recibió escitalopram, pero la hipersexualidad solo desapareció al disminuir la dosis de pramipexol; se inició levodopa/carbidopa y reapareció la hipersexualidad, que desapareció con la disminución de la dosis de levodopa/carbidopa. Conclusiones: Pramipexol podría estar asociado a hipersexualidad; pero, es necesario tener en cuenta las características relacionadas a cada enfermedad, así como los factores individuales. La hipersexualidad podría mejorar con el escitalopram, siendo necesario tratar los síntomas asociados.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2010-03-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/7210.15381/anales.v71i1.72Anales de la Facultad de Medicina; Vol. 71 No. 1 (2010); 51-3Anales de la Facultad de Medicina; Vol. 71 Núm. 1 (2010); 51-31609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72/67Derechos de autor 2010 Nilton Custodio, Rosa Montesinos, David Lira, Hernando Torreshttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/722020-04-15T17:40:35Z
score 13.888049
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).